These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

225 related articles for article (PubMed ID: 11776406)

  • 21. Comparative histological studies on liver of mice exposed to Cr(VI) and Cr(V) compounds.
    das Neves RP; Santos TM; Pereira Mde L; de Jesus JP
    Hum Exp Toxicol; 2002 Jul; 21(7):365-9. PubMed ID: 12269698
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Chromium hexavalent compounds.
    Rep Carcinog; 2004; 11():III63-6. PubMed ID: 21089834
    [No Abstract]   [Full Text] [Related]  

  • 23. An assessment and quantitative uncertainty analysis of the health risks to workers exposed to chromium contaminated soils.
    Paustenbach DJ; Meyer DM; Sheehan PJ; Lau V
    Toxicol Ind Health; 1991 May; 7(3):159-96. PubMed ID: 1949057
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Pro-oxidative vs antioxidative properties of ascorbic acid in chromium(VI)-induced damage: an in vivo and in vitro approach.
    Poljsak B; Gazdag Z; Jenko-Brinovec S; Fujs S; Pesti M; Bélagyi J; Plesnicar S; Raspor P
    J Appl Toxicol; 2005; 25(6):535-48. PubMed ID: 16092082
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Chromium-induced genotoxicity and interference in human lymphoblastoid cell (TK6) repair processes.
    El-Yamani N; Zúñiga L; Stoyanova E; Creus A; Marcos R
    J Toxicol Environ Health A; 2011; 74(15-16):1030-9. PubMed ID: 21707427
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The role of chromium(V) in the mechanism of chromate-induced oxidative DNA damage and cancer.
    Sugden KD; Stearns DM
    J Environ Pathol Toxicol Oncol; 2000; 19(3):215-30. PubMed ID: 10983888
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Hexavalent chromium responsible for lung lesions induced by intratracheal instillation of chromium fumes in rats.
    Toya T; Fukuda K; Kohyama N; Kyono H; Arito H
    Ind Health; 1999 Jan; 37(1):36-46. PubMed ID: 10052298
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Reduction of chromium(VI) and its relationship to carcinogenesis.
    Shi X; Chiu A; Chen CT; Halliwell B; Castranova V; Vallyathan V
    J Toxicol Environ Health B Crit Rev; 1999; 2(1):87-104. PubMed ID: 10081526
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Carcinogenicity of hexavalent chromium.
    Holmes AL; Wise SS; Wise JP
    Indian J Med Res; 2008 Oct; 128(4):353-72. PubMed ID: 19106434
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Genotoxicity and mutagenicity of chromium(VI)/ascorbate-generated DNA adducts in human and bacterial cells.
    Quievryn G; Peterson E; Messer J; Zhitkovich A
    Biochemistry; 2003 Feb; 42(4):1062-70. PubMed ID: 12549927
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Chromium.
    Barceloux DG
    J Toxicol Clin Toxicol; 1999; 37(2):173-94. PubMed ID: 10382554
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Molecular effects of chromium compound activity].
    Woźniak K
    Postepy Hig Med Dosw; 1996; 50(4):383-94. PubMed ID: 9019747
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Oxidative activation of the human carcinogen chromate by arsenite: a model for synergistic metal activation leading to oxidative DNA damage.
    Sugden KD; Rigby KM; Martin BD
    Toxicol In Vitro; 2004 Dec; 18(6):741-8. PubMed ID: 15465638
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Mechanistic insights from the NTP studies of chromium.
    Witt KL; Stout MD; Herbert RA; Travlos GS; Kissling GE; Collins BJ; Hooth MJ
    Toxicol Pathol; 2013 Feb; 41(2):326-42. PubMed ID: 23334696
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Chromium(VI) induced alterations in mouse spleen cells: a short-term assay.
    das Neves RP; Santos TM; de Pereira ML; de Jesus JP
    Cytobios; 2001; 106 Suppl 1():27-34. PubMed ID: 11534826
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Can the effects of chromium compounds exposure be modulated by vitamins and microelements?
    Sijko M; Janasik B; Wąsowicz W; Kozłowska L
    Int J Occup Med Environ Health; 2021 Aug; 34(4):461-490. PubMed ID: 33734217
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Lipoperoxidation products and thiol antioxidants in chromium exposed workers.
    Goulart M; Batoréu MC; Rodrigues AS; Laires A; Rueff J
    Mutagenesis; 2005 Sep; 20(5):311-5. PubMed ID: 15985443
    [TBL] [Abstract][Full Text] [Related]  

  • 38. An evaluation of the mode of action framework for mutagenic carcinogens case study II: chromium (VI).
    McCarroll N; Keshava N; Chen J; Akerman G; Kligerman A; Rinde E
    Environ Mol Mutagen; 2010 Mar; 51(2):89-111. PubMed ID: 19708067
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Mutagenic and carcinogenic actions of chromium and its compounds.
    Mamyrbaev AA; Dzharkenov TA; Imangazina ZA; Satybaldieva UA
    Environ Health Prev Med; 2015 May; 20(3):159-67. PubMed ID: 25877777
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Chromium(VI) enhances (+/-)-anti-7beta,8alpha-dihydroxy-9alpha,10alpha-epoxy-7,8,9,10-tetrahydrobenzo[a]pyrene-induced cytotoxicity and mutagenicity in mammalian cells through its inhibitory effect on nucleotide excision repair.
    Hu W; Feng Z; Tang MS
    Biochemistry; 2004 Nov; 43(44):14282-9. PubMed ID: 15518579
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.